相关实验视频
Updated: Jul 18, 2025

05:51
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
13.2K
动脉样硬化中炎症的分子和细胞机制
Nicoleta-Monica Popa-Fotea1,2, Corina-Elena Ferdoschi1, Miruna-Mihaela Micheu2
1Department 4 Cardio-Thoracic Pathology, University of Medicine and Pharmacy "Carol Davila," Bucharest, Romania.
Frontiers in cardiovascular medicine
|August 21, 2023
概括
炎症驱动动动脉硬化,这是一个复杂的疾病. 这篇评论详细介绍了免疫细胞和诸如细胞因子之类的调解者如何激活促进斑块发育和并发症的途径.
科学领域:
- 心血管科学 心血管科学
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 动脉样硬化是全球主要的死亡原因,尽管再血管治疗的进展.
- 炎症是动脉样硬化斑块的开始,进展和并发症中的一个中心,多步骤的过程.
研究的目的:
- 在动脉样硬化中审查细胞轴激活.
- 阐明炎症驱动动动脉硬化的特定机制和途径.
主要方法:
- 关于动脉样硬化的细胞和分子机制的文献综述.
- 免疫系统参与和调解器功能的分析.
主要成果:
- 免疫系统的激活增强了各种细胞 (内皮,光滑肌肉,血小板) 的亲动脉功能.
- 细胞因子通过刺激免疫细胞和进一步的细胞因子产生来调解炎症.
- 细胞间的相互作用也直接导致动脉样硬化动态.
结论:
- 炎症是动脉样硬化的关键驱动因素,涉及复杂的细胞轴相互作用.
- 了解这些炎症途径是开发新型治疗策略的关键.
相关概念视频
Atherosclerosis I: Introduction
10
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
10
Inflammation
53.8K
Overview
53.8K
Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Inflammatory Response I: Vascular and Cellular
11.3K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
11.3K
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12

